Literature DB >> 12928380

Interaction of murine precursor B cell receptor with stroma cells is controlled by the unique tail of lambda 5 and stroma cell-associated heparan sulfate.

Harald Bradl1, Jürgen Wittmann, Doreen Milius, Christian Vettermann, Hans-Martin Jäck.   

Abstract

Efficient clonal expansion of early precursor B (pre-B) cells requires signals delivered by an Ig-like integral membrane complex, the so-called pre-B cell receptor (pre-BCR). A pre-BCR consists of two membrane micro H chains, two covalently associated surrogate L chains, and the heterodimeric signaling transducer Igalphabeta. In contrast to a conventional Ig L chain, the surrogate L chain is a heterodimer composed of the invariant polypeptides VpreB and lambda5. Although it is still unclear how pre-BCR signals are initiated, two recent findings support a ligand-dependent initiation of pre-BCR signals: 1) a pre-BCR/galectin-1 interaction is required to induce phosphorylation of Igalphabeta in a human precursor B line, and 2) soluble murine as well as human pre-BCR molecules bind to stroma and other adherent cells. In this study, we show that efficient binding of a soluble murine pre-BCR to stroma cells requires the non-Ig-like unique tail of lambda5. Surprisingly however, a murine pre-BCR, in contrast to its human counterpart, does not interact with galectin-1, as revealed by lactose blocking, RNA interference, and immunoprecipitation assays. Finally, the binding of a murine pre-BCR to stroma cells can be blocked either with heparin or by pretreatment of stroma cells with heparitinase or a sulfation inhibitor. Hence, efficient binding of a murine pre-BCR to stroma cells requires the unique tail of lambda5 and stroma cell-associated heparan sulfate. These findings not only identified heparan sulfate as potential pre-BCR ligands, but will also facilitate the development of appropriate animal models to determine whether a pre-BCR/heparan sulfate interaction is involved in early B cell maturation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12928380     DOI: 10.4049/jimmunol.171.5.2338

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Mechanism for pre-B cell loss in VH-mutant rabbits.

Authors:  Gregory R Robbins; Katherine L Knight
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

Review 2.  Adhesion receptors involved in HSC and early-B cell interactions with bone marrow microenvironment.

Authors:  Maria De Grandis; Anne-Catherine Lhoumeau; Stéphane J C Mancini; Michel Aurrand-Lions
Journal:  Cell Mol Life Sci       Date:  2016-02       Impact factor: 9.261

3.  Precursor B cell receptor signaling activity can be uncoupled from surface expression.

Authors:  F Betul Guloglu; Christopher A J Roman
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

4.  Engineering and characterization of a single chain surrogate light chain variable domain.

Authors:  Lucia Morstadt; Andrew Bohm; Deniz Yüksel; Krishna Kumar; B David Stollar; James D Baleja
Journal:  Protein Sci       Date:  2008-03       Impact factor: 6.725

Review 5.  B lymphocytes: how they develop and function.

Authors:  Tucker W LeBien; Thomas F Tedder
Journal:  Blood       Date:  2008-09-01       Impact factor: 22.113

Review 6.  Inflammatory immune cells may impair the preBCR checkpoint, reduce new B cell production, and alter the antibody repertoire in old age.

Authors:  Richard L Riley; Kelly Khomtchouk; Bonnie B Blomberg
Journal:  Exp Gerontol       Date:  2018-02-07       Impact factor: 4.032

Review 7.  Checkpoints that control B cell development.

Authors:  Fritz Melchers
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

8.  N-linked glycosylation selectively regulates autonomous precursor BCR function.

Authors:  Rudolf Ubelhart; Martina P Bach; Cathrin Eschbach; Thomas Wossning; Michael Reth; Hassan Jumaa
Journal:  Nat Immunol       Date:  2010-07-11       Impact factor: 25.606

Review 9.  Cell circuits and niches controlling B cell development.

Authors:  Sandra Zehentmeier; João P Pereira
Journal:  Immunol Rev       Date:  2019-05       Impact factor: 12.988

Review 10.  Checkpoints in lymphocyte development and autoimmune disease.

Authors:  Harald von Boehmer; Fritz Melchers
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.